The data underlying the results of this study are third party data from the South Korean government agency, Korea Centers of Disease Control (KCDC), and are only available upon request. The authors were allowed to use the data from the KCDC and Korean Society of Heart Failure (KSHF) on requested topics and that are not yet open to the public. The KorAHF (KORea Acute Heart Failure) registry is strictly managed by the KCDC and KSHF, which provides the data to researchers at the contribution of each institution to the cohort enrollment. Those who are interested in related data may contact and request the data from KCDC or KSHF in South Korea via e-mail to <sangeunlee.md@gmail.com> or <khfs2@khfs.or.kr>, respectively. The authors did not have any special access or privileges to the data that others would not have.

Introduction {#sec004}
============

Approximately 26 million adults worldwide have heart failure, and acute heart failure (AHF) is the leading cause of hospitalization in Europe and the United States, resulting in more than 1 million admissions, and representing 1%--2% of all hospitalizations.\[[@pone.0219302.ref001],[@pone.0219302.ref002]\] In the past decades, the mortality rate of AHF has improved with advances in treatment, but AHF is still a leading cause of mortality worldwide.\[[@pone.0219302.ref001]--[@pone.0219302.ref003]\] Risk stratification and prognosis prediction are critical in identifying high-risk patients and decision making for the treatment of patients with AHF.

There are several mortality prediction models for heart failure, such as Get with the Guidelines-Heart Failure (GWTG-HF) score, Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score.\[[@pone.0219302.ref004],[@pone.0219302.ref005]\] However, these prognostic models have limitations for the current daily practice. First, GWTG-HF and MAGGIC are limited in specific situations. GWTG-HF and MAGGIC were developed only for in-hospital and long-term mortality, respectively.\[[@pone.0219302.ref004],[@pone.0219302.ref005]\] Second, because the accuracies of these methods are unsatisfactory, these methods cannot be used to decide the treatment of the patient. Third, these models use only limited information that is based on a conventional statistical approach, such as multivariate analysis by the logistic regression model that has a potential limitation of information loss.\[[@pone.0219302.ref006]--[@pone.0219302.ref008]\]

Recently, artificial intelligence algorithm has achieved a high performance in several medical domains, such as image detection and clinical outcome prediction.\[[@pone.0219302.ref009]--[@pone.0219302.ref011]\] An advantage of deep-learning is the automatic learning of the feature and relationship from a given data.\[[@pone.0219302.ref012]\] In this study, we developed and validated a deep-learning-based artificial intelligence algorithm for predicting mortality of patients with acute heart failure (DAHF) by using a large data from 12 hospitals.

Methods {#sec005}
=======

Study population {#sec006}
----------------

We conducted a retrospective observational cohort study using AHF patient data from 10 university hospitals of the Korean Acute Heart Failure (KorAHF) registry and 2 hospitals (hospital A: cardiovascular teaching hospital and hospital B: community general hospital), as shown in [Fig 1](#pone.0219302.g001){ref-type="fig"}. We defined patients with AHF as patients with signs or symptoms of heart failure and those who met either of the following criteria: 1) lung congestion or 2) objective left ventricular systolic dysfunction or structural heart disease findings.

![Study flowchart.\
KorAHF denotes Korean Acute Heart Failure registry.](pone.0219302.g001){#pone.0219302.g001}

First, we collected the algorithm train data of patients with AHF admitted in hospitals A and B from October 2016 to December 2017. The data obtained through the electronic health records of the two hospitals were demographic information, treatment and medication, laboratory results, electrocardiography (ECG) and echocardiography findings, final diagnosis, clinical outcome during their hospital stay, and 12-month prognosis after discharge.

Second, we used the data of patients with AHF enrolled in KorAHF as performance test data. KorAHF is a prospective multicenter registry of AHF in Korean patients. All cardiovascular centers in 10 tertiary university hospitals were included in KorAHF from March 2011 to January 2014. The full details of the KorAHF registry's aims and protocols have been published elsewhere.\[[@pone.0219302.ref013]\] The data obtained through KorAHF demographic information, treatment and medication, laboratory results, electrocardiography (ECG) and echocardiography findings, final diagnosis, clinical outcome during their hospital stay, 12-month prognosis, and 36-month prognosis.

Because hospitals A and B were not university hospitals, they were excluded in KorAHF. Moreover, the periods of the train data were different with the test data. Therefore, train and test data were completely separated. We excluded patients with missing values of predictor variables and endpoints as shown in [Fig 1](#pone.0219302.g001){ref-type="fig"}.

This study was conducted in accordance with the Declaration of Helsinki and the relevant guidelines and regulations. The institutional review boards (IRBs) of Sejong General Hospital (2018--0839) and Mediplex Sejong Hospital (2018--073) approved this study protocol and granted waivers of informed consent based on general impracticability and minimal harm. Patient information was anonymized and de-identified before the analysis. KorAHF data were collected by each site and approved by the IRB at each hospital. The KorAHF committee approved and provided data for the present study.

Data management {#sec007}
---------------

We used the data of hospital A and B as train data for prediction algorithm development. And we used the data of KorAHF as test data to confirm whether the DAHF can be applied to other hospitals after development. These two data were completely separated.

The DAHF is a risk stratification model for predicting in-hospital mortality and long-term mortality of patients with AHF at the time of admission. We used the demographic information, ECG, echocardiography, and laboratory data of patients with AHF, including age (years), sex (male or female), body mass index (BMI, kg/m^2^), systolic blood pressure (SBP, mmHg), diastolic blood pressure (DBP, mmHg), heart rate (HR, bpm), present atrial fibrillation (Afib, yes or no), QRS duration (QRS, ms), corrected QT interval (QTc, ms), left atrial dimension (LAD, mm), left ventricular dimension end-diastole (LVDd, mm), left ventricular dimension end-systole (LVDs, mm), ejection fraction (EF, %), white blood cell (WBC, /mL), hemoglobin (g/dL), platelet (/mL), albumin (g/dL), sodium (mmol/L), potassium (mmol/L), blood urea nitrogen (BUN, mg/dL), creatinine (Cr, mg/dL), and glucose (mg/dL), as the predictor variables.

In the train data of hospital A and B, we made a train dataset each time an ECG was taken during the hospital stay of the patient, as shown in [Fig 2](#pone.0219302.g002){ref-type="fig"}. If the value of other variables was missing during ECG, we used the most recent values of the demographic information and vital signs, and echocardiography and laboratory findings, as shown in [Fig 2](#pone.0219302.g002){ref-type="fig"}. Hence, several train datasets were generated from one patient. Using this method, we amplified and created a dataset sufficient for developing machine- and deep-learning methods.

![Train and validation of deep-learning prediction model.\
DAHF denotes deep-learning-based artificial intelligence algorithm for predicting mortality of patients with acute heart failure. Abbreviations: DBP, diastolic blood pressure; DNN, deep neural network; ECHO, echocardiography; ECG, electrocardiography; Hb, hemoglobin; LAD, left atrium dimension; LVDd, left ventricle end-diastolic dimension; QRS, QRS duration; QTc, corrected QT duration.](pone.0219302.g002){#pone.0219302.g002}

In the test data of KorAHF, only initial value of the demographic information, vital sign, ECG, echocardiography, and laboratory data at the time of admission were used. If the value of variable was missing during admission, the first result during hospital stay was used. Because the purpose of test dataset was to assess the accuracy of each prediction model, and the goal of each model was to predict the patient's prognosis at the time of admission, we generated only one test dataset from one patient.

Endpoints {#sec008}
---------

The difference of accuracy to predict in-hospital mortality and 12- and 36-month mortality in each prediction model was evaluated. The primary endpoint, in-hospital mortality, was defined as in-hospital death occurring during hospitalization. Readmission within 24 h was considered as the same hospital period. The secondary endpoints, 12- and 36-month mortality, were defined as death within 12 and 36 months, respectively, among patients who survived to discharge, as shown in [Fig 1](#pone.0219302.g001){ref-type="fig"}.

Development of deep- and machine-learning prediction models {#sec009}
-----------------------------------------------------------

We developed the DAHF by using only the train dataset. The DAHF was developed by using deep neural network (DNN), a method of deep-learning with 3 hidden layers, 33 nodes, batch normalization, and dropout layers.\[[@pone.0219302.ref014],[@pone.0219302.ref015]\] We used *TensorFlow* (the Google Brain Team, Mountain View, United States) as the backend.\[[@pone.0219302.ref016]\] In this DNN, we used a rectified linear unit (ReLU) and back propagation as the activation function and method of training, respectively. We developed DAHF by ensembling a DNN model fitted to in-hospital death and a DNN model fitted to 12-month death, as shown in [Fig 2](#pone.0219302.g002){ref-type="fig"}. We provided a detailed description, reference, and figure of the DNN as [S1 File](#pone.0219302.s001){ref-type="supplementary-material"}.

We also developed four machine-learning models, random forest (RF), logistic regression (LR), supportive vector machine (SVM), and Bayesian network (BN), for the performance comparison with DAHF.\[[@pone.0219302.ref017]\] In the previous studies, these machine-learning models were the most typically used methods and showed better performance than traditional methods in several medical domains.\[[@pone.0219302.ref018],[@pone.0219302.ref019]\] We used *randomForest*, *glmulti*, *e1071*, and *bnlearn* packages in R (R Development Core Team, Vienna, Austria) for the development of RF, LR, SVM, and BN models, respectively. Moreover, we also provided the detailed description, references, and figures as [S1 File](#pone.0219302.s001){ref-type="supplementary-material"}. We analyzed the variable importance of LR, RF, SVM, BN, and DNN by using deviance difference, mean decrease Gini, sensitivity analysis, deviance difference, and AUC difference, respectively.

Test of prediction model performance {#sec010}
------------------------------------

After we developed the DAHF and machine-learning models, we compared the performance of these models with the conventional prediction scoring. We compared the performance for predicting in-hospital mortality with the GWTG-HF scores and compared the performance for predicting 12- and 36-months mortality with the MAGGIC scores.\[[@pone.0219302.ref004],[@pone.0219302.ref005]\] We compared the performance of the models by using only the test data not used for the model development. GWTG-HF and MAGGIC scores were well validated and used globally. We used the area under the receiver operating characteristic curve (AUC) as the comparative measure. The AUC is a frequently used metric, and the receiver operating characteristic curve shows the sensitivity against 1-specificity.\[[@pone.0219302.ref020]\] We evaluated the 95% confidence interval using bootstrapping (10,000 times resampling with replacement).\[[@pone.0219302.ref021]\] We used *ROCR* package in R (R Development Core Team, Vienna, Austria) for these analyses.

We divided the patients of the test data into the high- and low-risk groups based on the DAHF. In this analysis, we used the data of patients who survived to discharge. The optimal cutoff point of the DAHF score was determined when the Youden J statistics was at maximum.\[[@pone.0219302.ref022]\] After dividing the patients into risk groups, we estimated the 36-month mortality by risk groups by using the Kaplan--Meier method. We used the *pROC* and *survival* packages in R (R Development Core Team, Vienna, Austria) in this analysis.

Results {#sec011}
=======

We included 8094 patients with AHF (hospitals A and B: 2469; KorAHF: 5625) in the present study ([Fig 1](#pone.0219302.g001){ref-type="fig"}). We excluded 1170 patients because of missing values and endpoints. The study subjects comprised 6724 patients, wherein 194 were in-hospital mortalities. The DNN prediction model, DAHF, was developed using 12,654 train datasets from 2165 patients of hospitals A and B. The performance test was performed using 4759 test datasets from 4759 patients of KorAHF ([Fig 2](#pone.0219302.g002){ref-type="fig"}). [Table 1](#pone.0219302.t001){ref-type="table"} shows the baseline characteristics, and a significant difference was found between the characteristics of the train and test data.

10.1371/journal.pone.0219302.t001

###### Baseline characteristics[†](#t001fn001){ref-type="table-fn"}.

![](pone.0219302.t001){#pone.0219302.t001g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  　                               train data\                     Test data\           *p*-value[‡](#t001fn002){ref-type="table-fn"}                                        
                                   (Hospitals A and B, n = 2165)   (KorAHF, n = 4759)                                                                                        
  -------------------------------- ------------------------------- -------------------- ----------------------------------------------- ------------- ------------ --------- ---------
  **Demographics**                 　                              　                   　                                              　            　           　        \<0.001

      Age (years)                  65.1±14.2                       74.5±12.3            \<0.001                                         68.2±14.5     70.8±14.5    0.020     \<0.001

      Male (%)                     1246 (59.8)                     46 (56.1)            0.576                                           2411 (52.7)   103 (56.6)   0.336     \<0.001

      BMI (kg/m^2^)                24.5±11.2                       21.9±3.3             0.031                                           23.4±3.9      22.6±3.6     0.007     \<0.001

  **Vital signs at admission　**   　                              　                   　                                              　            　                     

      SBP (mmHg)                   120.1±19.9                      113.4±22.0           0.003                                           132.1±30.2    116.8±27.0   \<0.001   \<0.001

      DBP (mmHg)                   72.1±13.3                       67.7±13.4            0.004                                           79.2±18.7     70.2±19.3    \<0.001   \<0.001

      HR (bpm)                     80.0±21.7                       97.6±28.8            \<0.001                                         92.5±25.7     94.6±26.3    0.274     \<0.001

  **Electrocardiography**          　                              　                   　                                              　            　           　        

      AF (%)                       497 (23.9)                      31 (37.8)            0.006                                           1882 (41.1)   63 (34.6)    0.094     \<0.001

      QRS duration (ms)            101.9±23.8                      107.5±26.3           0.037                                           106.0±28.2    113.2±30.1   0.001     \<0.001

      QTc (ms)                     462.7±42.0                      470.8±43.8           0.087                                           475.0±46.0    474.7±48.0   0.937     \<0.001

  **Echocardiography　**           　                              　                   　                                              　            　           　        

      LAD (mm)                     44.2±9.6                        46.0±14.3            0.095                                           48.2±9.8      45.9±11.1    0.001     \<0.001

      LVDd (mm)                    51.6±8.1                        49.8±9.7             0.056                                           57.5±10.1     56.6±10.9    0.233     \<0.001

      LVDs (mm)                    36.7±10.3                       36.7±11.0            0.962                                           45.2±12.4     45.6±12.4    0.714     \<0.001

      EF (%)                       44.7±14.0                       37.8±14.8            \<0.001                                         37.9±15.5     33.3±15.9    \<0.001   \<0.001

  **Laboratory test**              　                              　                   　                                              　            　           　        　

      WBC (/mL)                    7954.7\                         13864.1\             \<0.001                                         8494.2\       10639.6\     \<0.001   \<0.001
                                   ±2997.2                         ±7580.7                                                              ±3714.4       ±5317.2                

      Hb (g/dL)                    12.5±2.2                        10.2±1.9             \<0.001                                         12.5±2.3      11.9±2.3     0.001     0.203

      Platelets (/mL)              242,838.69\                     161,573.2\           \<0.001                                         211,782.8\    197,033.0\   0.030     \<0.001
                                   ±91,419.2                       ±101,270.7                                                           ±86,736.6     ±146,965.7             

      Alb(g/dL)                    4.0±0.6                         2.9±0.7              \<0.001                                         3.7±0.5       3.5±0.5      \<0.001   \<0.001

      Sodium (mmol/L)              138.7±3.6                       139.9±7.9            0.006                                           137.6±4.7     135.1±6.3    \<0.001   \<0.001

      Potassium (mmol/L)           4.2±0.5                         4.2±0.7              0.775                                           4.4±0.7       4.6±0.9      \<0.001   \<0.001

      BUN (mg/dL)                  20.7±13.5                       38.5±24.2            \<0.001                                         25.6±15.8     36.4±24.8    \<0.001   \<0.001

      Cr (mg/dL)                   1.3±1.4                         1.8±1.3              0.001                                           1.4±1.4       1.9±1.7      \<0.001   \<0.001

      Glucose (mg/dL)              130.9±52.8                      175.0±94.6           \<0.001                                         153.0±74.8    166.5±83.0   0.018     \<0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

† AF, atrial fibrillation; Alb, albumin; BMI, body mass index; BUN, blood urea nitrogen; Cr, creatinine; DBP, diastolic blood pressure; EF, ejection fraction; Hb, hemoglobin; HR, heart rate; KorAHF, Korean Acute Heart Failure registry; LAD, left atrial dimension; LVDd, left ventricular dimension end-diastole; LVDs, left ventricular dimension end-systole; QTc, corrected QT interval; SBP, systolic blood pressure; WBC, white blood cell.

‡ Alternative hypothesis for this *p*-value: a difference is found between the train and test data groups.

\* Alternative hypothesis for this *p*-value: a difference is found between the survivor and in-hospital mortality groups.

[Fig 3](#pone.0219302.g003){ref-type="fig"} shows that the AUC of the DAHF was 0.880 (95% confidence interval, 0.876--0.884\]) during the performance test for predicting in-hospital mortality, and this result significantly outperformed the GWTG-HF score (0.728 \[0.720--0.737\]) and other machine-learning prediction models. [Fig 4](#pone.0219302.g004){ref-type="fig"} shows that the AUCs of the DAHF were 0.782 \[0.779--0.785\] and 0.813 \[0.810--0.816\], respectively, during the performance test for predicting 12- and 36-month mortality. Moreover, these performances significantly outperformed the MAGGIC score (0.718 \[0.714--0.723\] and 0.729 \[0.726--0.733\]) and other machine-learning prediction models.

![Receiver operating characteristic curve for predicting in-hospital mortality.\
AUC, area under the receiver operating characteristic curve; CI, confidence interval; GWTG-HF, Get with the Guideline--Heart Failure.](pone.0219302.g003){#pone.0219302.g003}

![Receiver operating characteristic curves for predicting long-term mortalities.\
AUC, area under the receiver operating characteristic curve; CI, confidence interval; MAGGIC, Meta-Analysis Global Group in Chronic Heart Failure.](pone.0219302.g004){#pone.0219302.g004}

In the train dataset, the optimal cut-off scores of the DAHF risk groups were 0.472. Among 4577 survival-to-discharge patients in the test dataset, the DAHF classified 2668 and 1909 patients as high and low risk, respectively. The cumulative hazard plot of [Fig 5](#pone.0219302.g005){ref-type="fig"}. shows that the high-risk group of the DAHF shows a significantly higher hazard than the low-risk group. The high-risk group, defined by the DAHF, has a significantly higher mortality rate than the low-risk group (*p*\<0.001).

![Cumulative hazard of 36-month mortality by deep-learning-based algorithm risk group.](pone.0219302.g005){#pone.0219302.g005}

The characteristics and variable importance of each prediction model is shown in [S2 File](#pone.0219302.s002){ref-type="supplementary-material"}. The variable importance is different for each prediction model. In the conventional machine-learning models, the *EF* and *QRS duration* variables are less important for prediction. However, for the DAHF, these variables are important for prediction ([S2 File](#pone.0219302.s002){ref-type="supplementary-material"}). The *BMI* and *LAD* variables are less important for prediction in DAHF than other conventional machine-learning prediction models.

Discussion {#sec012}
==========

In this study, we developed a deep-learning-based artificial intelligence algorithm, DAHF, for predicting the mortality of patients with AHF using two hospital datasets and validated DAHF using separated AHF registry data. This study revealed that the accuracy of performance of the deep-learning-based artificial intelligence model was excellent for predicting the mortalities and is better than the conventional risk score model. In addition, the deep-learning model outperformed other machine-learning prediction models to predict endpoints. To the best of our knowledge, this study is the first to predict AHF patient endpoints using deep-learning-based artificial intelligence prediction models.

The GWTG-HF and MAGGIC scores are well validated conventional models for risk stratification of AHF patients.\[[@pone.0219302.ref023]--[@pone.0219302.ref026]\] The previous validation studies have reported that the AUC of the GWTG-HF scores for predicting in-hospital mortality of patients with AHF was 0.71--0.76.\[[@pone.0219302.ref024],[@pone.0219302.ref025]\] Furthermore, the AUC of the MAGGIC score for predicting 1--3-year mortality of patients with AHF in previous studies was 0.73--0.74, implying moderate accuracy for predicting the mortality of patients with AHF.\[[@pone.0219302.ref024],[@pone.0219302.ref026]\] These results were similar with those of this study.

However, the GWTG-HF and MAGGIC scores have several limitations. First, these models were developed and validated on specific situations. The GWTG-HF was developed to predict in-hospital mortality, and MAGGIC score was developed and validated to predict long-term endpoints.\[[@pone.0219302.ref004],[@pone.0219302.ref005]\] Moreover, these prediction scoring methods had no satisfactory performance and were not actively used to decide the treatment of the patient. Because these scoring models were developed by the conventional statistical approach using the logistic regression model that has limitations, including the fixed assumptions on data behavior, and the necessity to preselect variables in the development phase, thus leading to potential information loss. \[[@pone.0219302.ref006]--[@pone.0219302.ref008]\]

Unlike the conventional statistical approach, deep-learning does not require the preselection of important variables, and the less important variables are naturally ignored in the model fitting process.\[[@pone.0219302.ref012],[@pone.0219302.ref014],[@pone.0219302.ref015]\] Furthermore, deep-learning does not limit the number of input predictive factors and can use all available information without potential loss. Subsequently, the old models cannot reflect the relationship between variables. This is because the risk is measured only by the sum of the variables. Meanwhile, deep-learning obtains the relationship between the variables, as shown in [S1 File](#pone.0219302.s001){ref-type="supplementary-material"}, unlike conventional methods.\[[@pone.0219302.ref012],[@pone.0219302.ref014],[@pone.0219302.ref015]\]

The previous studies have attempted to predict prognosis, such as readmission and mortalities of AHF, by using conventional machine-learning prediction models.\[[@pone.0219302.ref018],[@pone.0219302.ref019]\] In the present study, we confirmed that DNN outperformed other conventional machine-learning prediction models, such as RF, LR, SVM, and BN. The machine-learning prediction model required careful engineering to design a feature extractor for selecting important variables.\[[@pone.0219302.ref017]\] This process requires a lot of manpower, and loss of important information is possible. Deep-learning, DNN, including feature-learning process, which is a set of methods that allow a model to be fed with raw data and to automatically identify the feature needed for conducting a task.\[[@pone.0219302.ref012],[@pone.0219302.ref014],[@pone.0219302.ref015]\] Deep-learning comprises multiple processing layers of feature as shown in [S1 File](#pone.0219302.s001){ref-type="supplementary-material"}, obtained by composing simple but non-linear modules, each of which transforms the feature at one level (starting with the raw input) into a feature at a higher and more abstract level. Because this process is conducted automatically, it is good at discovering the intricate structures in high-dimensional data without information loss and it requires only very little engineering by human.\[[@pone.0219302.ref012],[@pone.0219302.ref014],[@pone.0219302.ref015]\] Therefore, deep-learning can be quickly applied to tasks with ease and outperform other conventional machine-learning models.

Deep- and machine-learning models are used to obtain the relationship between the predictor and outcome variables, rather than creating a rule based on medical knowledge. Hence, the performance of machine- and deep-learning models is not guaranteed in other situations. Wolpert explains the no-free-lunch theorem; if optimized in one situation, a model cannot produce good results in other situations.\[[@pone.0219302.ref027]\] Because deep- and machine-learning models can over-fit with the characteristics of hospitals in train data, we conducted a performance test using complete separated test data, which were not used for the model development.

In the present study, we amplified the train dataset from the data of the train group patients by using the methods of collecting multiple datasets from a patient data. Using these methods, we collected a sufficient amount of dataset for developing deep- and machine-learning models. Deep- and machine-learning models require an abundant amount of data for its development. Because the available data are limited, and the outcomes to be predicted are highly diverse in the medical field, this method is promising to future studies in medical domains and will inspire many researchers.

Deep- and other machine-learning predicted models predicted endpoints using different structures as shown in [S1 File](#pone.0219302.s001){ref-type="supplementary-material"}. The patients for which each model correctly predicted the endpoints also differed. Furthermore, the variable importance of DAHF is different from that of RF, LF, SVM, and BN, as shown in [S2 File](#pone.0219302.s002){ref-type="supplementary-material"}. Therefore, different algorithms can complement the other weaknesses of the algorithms. We used the combination of two deep-learning algorithm, DNNs, for predicting both in-hospital and long-term mortality simultaneously, and this method was called *ensemble*.\[[@pone.0219302.ref028]\] Many researchers attempted to improve the accuracy by combining diverse predictive algorithms. This method is also called an *ensemble* algorithm.

Our study has several limitations. First, the deep-learning model is known as a "black box." Although we can fit and develop the deep-learning based artificial intelligence model, we cannot interpret the model in terms of the approach to the decision of risk score. For example, if the DAHF predicts a high risk of mortality for a patient, the reason for that decision cannot be ascertained. Recently, an interpretable deep-learning model has been studied and will be our next area of study.\[[@pone.0219302.ref029],[@pone.0219302.ref030]\] Second, this prediction model was developed with limited variables that could be collected from the KorAHF registry. As shown in previous studies of Cacciatore, functional parameters such as the 6-minute walking test is a good prognostic factor of cardiac diseases.\[[@pone.0219302.ref031]\] We plan to use more information of HF patients that can enhance the performance of the AI algorithm with more valuable variables. Third, this study was conducted with retrospective big data. Thus, we could not extract accurate past medical histories such as respiratory diseases and malignancies that could also affect long-term mortality. We plan to conduct a prospective study for validating the AI algorithm and confirm the correlation between medical history and HF in our next research.

Conclusions {#sec013}
===========

In conclusion, we developed and validated a new mortality prediction artificial intelligence model of AHF based on the deep-learning approach. The deep-learning algorithm, DAHF, predicted the in-hospital, 12- and 36-month mortality of patients with AHF more accurately than the existing risk scores and other machine-learning methods. This study showed the feasibility and effectiveness of the deep-learning-based artificial intelligence algorithm model for cardiology, which can be a useful tool for precise decision making in daily practice.
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AHF

:   acute heart failure
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:   area under the receiver operating characteristic curve

BN

:   Bayesian network

DAHF

:   deep-learning-based artificial intelligence algorithm for predicting mortality of patients with acute heart failure

DNN

:   deep neural network

GWTG-HF

:   Get with the Guidelines--Heart Failure

LR

:   logistic regression

MAGGIC

:   Meta-Analysis Global Group in Chronic Heart Failure
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:   random forest

SVM

:   support vector machine

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
